Health Law Daily Wrap Up, BLOG TRACKER—Noteworthy blog posts and other commentary, (Aug 15, 2024)

By WK Editorial Staff

The week’s most insightful, intriguing, or entertaining blog posts from the health law community.

• FDA Law Blog: CMS Issues Proposed Rule on the Medicare Part B and Part D Inflation Rebate Program; HPM Issues Detailed Summary, by Alan M. Kirschenbaum, Michelle L. Butler, Faraz Siddiqui and Sophia R. Gaulkin

• Healthcare Law Blog, IRS Audits & Ongoing Scrutiny of Nonprofit Hospitals – Key Background & Action Steps, by Tamar Rosenberg and Emma Arroyo

• Health Law News Blog: HIPAA-Regulated Entities Required to Comply with New Rules to Support Reproductive Health Care Privacy by the End of the Year, by Stephane P. Fabus

• The Incidental Economist Blog, The United States’ Organ Procurement and Transplantation Network: An Overview, by Katherine O'Malley

• FDA Law Update: Krazati Untitled Letter: A Cautionary Tale for CFL Promotion of Accelerated Approval Drugs, by Dominick DiSabatino and Cortney Inman

• Healthcare Economist Blog: How to fast track approval and reimbursement of innovative medicines, by Jason Shafrin

Have you seen (or written) a blog post that fits the bill? Send the HLD editors a note at HLD@wolterskluwer.com, with a link to the suggested post.

Attorneys: Alan M. Kirschenbaum, Michelle L. Butler, Faraz Siddiqui and Sophia R. Gaulkin (Hyman, Phelps & McNamara, P.C.). Tamar Rosenberg and Emma Arroyo (Sheppard, Mullin, Richter & Hampton LLP). Stephane P. Fabus (Hall, Render, Killian, Heath & Lyman, P.C.). Dominick DiSabatino and Cortney Inman (Sheppard, Mullin, Richter & Hampton LLP).

IndustryNews: NewsStory AgencyNews GeneralNews ReimbursementNews ComplianceNews DrugNews MDNews CMSNews FDCActNews MDeviceNews DrugBiologicNews